|
ASX - By Stock
|
RCE |
Re:
Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion
|
|
fungus123
|
34 |
13K |
7 |
18/01/24 |
| 18/01/24 |
ASX - By Stock
|
34
|
13K
|
7
|
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
fungus123
|
177 |
81K |
6 |
18/01/24 |
| 18/01/24 |
ASX - By Stock
|
177
|
81K
|
6
|
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 CF33-hNIS Study Update - Positive Early Signals
|
|
fungus123
|
177 |
81K |
1 |
17/01/24 |
| 17/01/24 |
ASX - By Stock
|
177
|
81K
|
1
|
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New PD1-Vaxx Phase 2 CRC Cancer Trial to Open in UK and AUS
|
|
fungus123
|
74 |
30K |
0 |
08/12/23 |
| 08/12/23 |
ASX - By Stock
|
74
|
30K
|
0
|
|
|
ASX - By Stock
|
RCE |
Re:
Ann: DFI Clinical Trial Outpatient Nurses Appointed
|
|
fungus123
|
26 |
11K |
5 |
01/06/23 |
| 01/06/23 |
ASX - By Stock
|
26
|
11K
|
5
|
|
|
ASX - By Stock
|
RCE |
Re:
Ann: DFI Clinical Trial Outpatient Nurses Appointed
|
|
fungus123
|
26 |
11K |
12 |
01/06/23 |
| 01/06/23 |
ASX - By Stock
|
26
|
11K
|
12
|
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial
|
|
fungus123
|
28 |
10K |
4 |
21/02/23 |
| 21/02/23 |
ASX - By Stock
|
28
|
10K
|
4
|
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
fungus123
|
2.1K |
635K |
1 |
06/08/21 |
| 06/08/21 |
ASX - By Stock
|
2.1K
|
635K
|
1
|
|